Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02227654 · ClinicalTrials.gov registry record · NA
Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors
A NA study, sponsored by Frederick R. Ueland, M.D..
- Completed
- Registry status
- NA
- Development phase
- 179
- Enrollment target
NCT02227654 is a NA study that has completed, run by Frederick R. Ueland, M.D.. The registered enrollment target is 179 participants.
The verdict
NCT02227654, a NA study, has completed, sponsored by Frederick R. Ueland, M.D..
- COMPLETED
- Registry status
- NA
- Development phase
- 179 participants
- Enrollment target
Study Summary
The present investigation will prospectively evaluate whether serial transvaginal ultrasonography with Morphology Index (MI) can further reduce false positive results by more accurately distinguishing benign from malignant ovarian tumors. If there is no change in the detection of true positive cases, the result will be an increase in the positive predictive value of ovarian cancer screening.
Interventions
- PROCEDURE Abnormal Ovarian Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2016-09-12 |
| Est. Completion | 2022-09-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02227654
The ClinicalTrials.gov registry entry for NCT02227654 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 179 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Frederick R. Ueland, M.D., which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Abnormal Ovarian Ultrasound is the first listed.
NCT02227654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02227654 about?
NCT02227654 is a clinical study titled "Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors". The present investigation will prospectively evaluate whether serial transvaginal ultrasonography with Morphology Index (MI) can further reduce false positive results by more accurately distinguishing benign from malignant ovarian tumors. If there is no change in the detection of true positive cases...
What is the current status of trial NCT02227654?
This trial is currently completed. It is a NA study. The enrollment target is 179 participants. The study started on 2016-09-12. Estimated completion is 2022-09-07.
What interventions are being tested in trial NCT02227654?
The interventions under investigation include: Abnormal Ovarian Ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT02227654?
This trial is sponsored by Frederick R. Ueland, M.D., which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.